You have 9 free searches left this month | for more free features.

selective serotonin reuptake inhibitor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Major Depressive Disorder With Anhedonia and Inadequate Response

Not yet recruiting
  • Depressive Disorder, Major
  • No Intervention
  • (no location specified)
Apr 24, 2023

Haemorrhage Between Vortioxetine Tablet Treatment and Selective

Not yet recruiting
  • Major Depressive Disorder
  • Vortioxetine Tablet
  • SSRI
  • (no location specified)
Jun 28, 2023

Selective Serotonin Reuptake Inhibitor on Cognition, Sexual

Recruiting
  • Menopause
  • Hormone replacement therapy
  • Selective serotonin reuptake inhibitors
  • São Bernardo do Campo, SP, Brazil
    Centro de Atenção Integral à Saúde da Mulher
Jan 20, 2022

Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,

Recruiting
  • Geriatric Depression
  • Cognitive Impairment
  • Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram)
  • Beijing, China
    Beijing Anding Hospital Affiliated to Capital Medical University
Oct 18, 2022

Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • aiTBS
  • +2 more
  • Ghent, East-Flanders, Belgium
    University Hospital Ghent
Dec 6, 2022

Major Depressive Disorder Who Have HadInadequate Response

Terminated
  • Depressive Disorder, Major
  • Standard of Care (SOC)
  • San Francisco, California
  • +3 more
Dec 6, 2022

Retinal Nerve Fiber Layer in First Episode Depressive Patients

Enrolling by invitation
  • Unipolar Depression
    • Diyarbakır, Turkey
      Sağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Resear
    Mar 16, 2021

    SSRI's and the Rate of Progression From MCI to Dementia

    Recruiting
    • Mild Cognitive Impairment
    • +2 more
    • Columbus, Ohio
      The Ohio State University
    Sep 8, 2021

    PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written

    Recruiting
    • PTSD
    • Selective serotonin reuptake inhibitor
    • +2 more
    • North Little Rock, Arkansas
    • +15 more
    Aug 2, 2022

    Risk Factors for AD-Associated Switch to Mania

    Completed
    • Bipolar Disorder
    • Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
    • Barcelona, Catalonia, Spain
      Hospital Clinic Barcelona
    Nov 17, 2021

    Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

    Completed
    • Depression
    • +7 more
    • Beating the Blues (BtB)
    • +3 more
    • Indianapolis, Indiana
      IUPUI Department of Psychology
    Aug 30, 2021

    Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • San Diego, California
    • +26 more
    Aug 17, 2022

    Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

    Not yet recruiting
    • Hypercapnia
    • Ventilatory Depression
    • Placebo and Oxycodone
    • +2 more
    • West Bend, Wisconsin
      Spaulding Clinical Research
    Jul 20, 2022

    Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

    Completed
    • Depressive Disorder, Major
    • Esketamine 28 mg
    • +6 more
    • Ciudad Autonoma de Buenos Aires, Argentina
    • +170 more
    Sep 13, 2022

    Pulmonary Arterial Hypertension Trial in Dallas (Fluoxetine)

    Completed
    • Pulmonary Arterial Hypertension
    • Dallas, Texas
      UT Southwestern Medical Center
    Jun 24, 2020

    Stroke Trial in Bordeaux, Toulouse (Fluoxetine, Placebo, fMRI)

    Unknown status
    • Stroke
    • Bordeaux, France
    • +1 more
    Jul 29, 2020

    Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of

    Withdrawn
    • Stroke, Ischemic
    • Administration of SSRI escitalopram
    • +2 more
    • White Plains, New York
      Burke Neurological Institute
    Jul 19, 2021

    Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin

    Withdrawn
    • Tracheostomy Complication
      • Columbus, Ohio
      • +1 more
      Nov 2, 2021

      MDD Trial in Dhaka (Magnesium Glycinate tablet 200mg, Placebo tablet 200mg)

      Completed
      • MDD
      • Magnesium Glycinate tablet 200mg
      • Placebo tablet 200mg
      • Dhaka, Bangladesh
        Basic Science and Paraclinical Science of BSMMU
      Mar 6, 2022

      Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)

      Not yet recruiting
      • Depression in Old Age
      • Fragility Fracture
      • Duloxetine 30 mg
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      May 9, 2023

      Prospective Clinical Cohort Study of Depression

      Not yet recruiting
      • Major Depressive Disorder
      • selective serotonin reuptake inhibitors
      • TMS
      • (no location specified)
      Mar 7, 2023

      Fibromyalgia, Depression Trial in Dokki (Physiotherapy protocol, Selective serotonin reuptake inhibitors (SSRI))

      Not yet recruiting
      • Fibromyalgia
      • Depression
      • Physiotherapy protocol
      • Selective serotonin reuptake inhibitors (SSRI)
      • Dokki, Egypt
        Outpatient clinic faculty of physica therapy cairo university
      Mar 24, 2023

      MDD Trial (Vortioxetine, Sertraline, citalopram)

      Active, not recruiting
      • Major Depressive Disorder
      • Catanzaro, Italy
      • +2 more
      Oct 7, 2022

      Bipolar Disorder, Major Depression Trial in Cleveland (Selective Serotonin Reuptake Inhibitor (SSRI))

      Completed
      • Bipolar Disorder
      • Major Depression
      • Selective Serotonin Reuptake Inhibitor (SSRI)
      • Cleveland, Ohio
        Cleveland Clinic Foundation Center for Behavioral Health
      Nov 26, 2019